{
  "url": "http://www.w3.org/1999/xhtml\"><!--",
  "content": "L_2017342NL.01008501.xml 21.12.2017 NL Publicatieblad van de Europese Unie L 342/85 Rectificatie van Verordening (EU) 2017/776 van de Commissie van 4 mei 2017 tot wijziging van Verordening (EG) nr. 1272/2008 van het Europees Parlement en de Raad betreffende de indeling, etikettering en verpakking van stoffen en mengsels, met het oog op de aanpassing aan de technische en wetenschappelijke vooruitgang ( Publicatieblad van de Europese Unie L 116 van 5 mei 2017 ) Bladzijde 8, punt 3, onder d), ii), van de bijlage tot wijziging van tabel 3 in deel 3 van bijlage VI bij Verordening (EG) nr. 1272/2008 moet als volgt worden gelezen: ii) de vermeldingen voor de catalogusnummers 006-046-00-8, 604-057-00-8, 605-023-00-5, 606-041-00-6, 607-123-00-4, 608-055-00-8, 612-150-00-X, 613-318-00-5, 614-001-00-4, 615-013-00-2, 616-006-00-7, 616-094-00-7 en 650-032-00-X worden vervangen door: Catalogusnummer Internationale chemische identificatie EG-nr. CAS-nr. Indeling Etikettering Specifieke concentratiegrenzen, M-factoren en ATE's Opmerkingen Gevarenklasse en categorie Gevarenaanduiding Pictogram, signaalwoord Gevarenaanduiding Aanvullende gevarenaanduiding „006-046-00-8 bendiocarb (ISO); 2,2-dimethyl-1,3-benzodioxol-4-yl-N-methylcarbamaat; 2,2-dimethyl-1,3-benzodioxol-4-yl-methylcarbamaat 245-216-8 22781-23-3 Acute Tox. 3 Acute Tox. 3 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H300 H400 H410 GHS06 GHS09 Dgr H331 H311 H300 H410 M = 10 M = 100” „604-057-00-8 reactiemassa van: isomeren van 2-(2H-benzotriazool-2-yl)-4-methyl-(n)-dodecylfenol; isomeren van 2-(2H-benzotriazool-2-yl)-4-methyl-(n)-tetracosylfenol; isomeren van 2-(2H-benzotriazool-2-yl)-4-methyl-5,6-didodecyl-fenol. n = 5 of 6 401-680-5 — Aquatic Chronic 4 H413 H413” „605-023-00-5 5-chloor-2-(4-chloorfenoxy)fenol; [DCPP] 429-290-0 3380-30-1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 M = 10 M = 10” „606-041-00-6 2-methyl-1-(4-methylthiofenyl)-2-morfolinopropaan-1-on 400-600-6 71868-10-5 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 H360FD H302 H411 GHS08 GHS07 GHS09 Dgr H360FD H302 H411” „607-123-00-4 2,3-epoxypropylmethacrylaat; glycidylmethacrylaat 203-441-9 106-91-2 Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 Acute Tox. 4 STOT SE 3 STOT RE 1 Eye Dam. 1 Skin Corr. 1C Skin Sens. 1 H350 H341 H360F H311 H302 H335 H372 (luchtwegen) (inademing) H318 H314 H317 GHS08 GHS06 GHS05 Dgr H350 H341 H360F H311 H302 H335 H372 (luchtwegen) (inademing) H314 H317 D” „608-055-00-8 fipronil (ISO); (±)-5-amino-1-(2,6-dichloor-α,α,α-trifluor-para-tolyl)-4-trifluormethylsulfinyl-pyrazool-3-carbonitril 424-610-5 120068-37-3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H301 H311 H331 H372 * H400 H410 GHS06 GHS08 GHS09 Dgr H301 H311 H331 H372 * H410 M = 1 000 M = 10 000 ” „612-150-00-X spiroxamine (ISO); 8-tert-butyl-1,4-dioxaspiro[4.5]decaan-2-ylmethyl(ethyl)(propyl)amine — 118134-30-8 Repr. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361d H332 H312 H302 H373 (oog) H315 H317 H400 H410 GHS08 GHS07 GHS09 Wng H361d H332 H312 H302 H373 (oog) H315 H317 H410 M = 100 M = 100” „613-318-00-5 fenpyrazamine (ISO); S-allyl-5-amino-2,3-dihydro-2-isopropyl-3-oxo-4-(o-tolyl)pyrazool-1-carbothioaat; S-allyl-5-amino-2-isopropyl-4-(2-methylfenyl)-3-oxo-2,3-dihydropyrazool-1-carbothioaat — 473798-59-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 10 M = 1” „614-001-00-4 nicotine (ISO); 3-[(2S)-1-methylpyrrolidine-2-yl]pyridine 200-193-3 54-11-5 Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 Aquatic Chronic 2 H330 H310 H300 H411 GHS06 GHS09 Dgr H330 H310 H300 H411 inademing: ATE = 0,19 mg/L (stofdeeltjes of nevels) dermaal: ATE = 70 mg/kg oraal: ATE ( *1 ) = 5 mg/kg” „615-013-00-2 cyaanamide; carbanonitril 206-992-3 420-04-2 Carc. 2 Repr. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Skin Corr. 1 Skin Sens. 1 Eye Dam. 1 Aquatic Chronic 3 H351 H361fd H311 H301 H373 (schildklier) H314 H317 H318 H412 GHS08 GHS06 GHS05 Dgr H351 H361fd H311 H301 H373 (schildklier) H314 H317 H412” „616-006-00-7 dichlofluanide (ISO); N-[(dichloorfluormethyl)thio]-N′,N′-dimethyl-N-fenylsulfamide 214-118-7 1085-98-9 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 H332 H319 H317 H400 GHS07 GHS09 Wng H332 H319 H317 H400 M = 10” „616-094-00-7 3,3′-dicyclohexyl-1,1′-methyleenbis(4,1-fenyleen)diureum 406-370-3 58890-25-8 Aquatic Chronic 4 H413 H413” „650-032-00-X cyproconazool (ISO); (2RS,3RS;2RS,3SR)-2-(4-chloorfenyl)-3-cyclopropyl-1-(1H-1,2,4-triazool-1-yl)butaan-2-ol — 94361-06-5 Repr. 1B Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H360D H301 H373 (lever) H400 H410 GHS08 GHS06 GHS09 Dgr H360D H301 H373 (lever) H410 M = 10 M = 1” Bladzijde 12, punt 3, onder d), iii), van de bijlage tot wijziging van tabel 3 in deel 3 van bijlage VI bij Verordening (EG) nr. 1272/2008 moet als volgt worden gelezen: iii) de volgende vermeldingen worden ingevoegd overeenkomstig de volgorde van de in tabel 3 opgenomen vermeldingen: Catalogusnummer Internationale chemische identificatie EG-nr. CAS-nr. Indeling Etikettering Specifieke concentratiegrenzen, M-factoren en ATE's Opmerkingen Gevarenklasse en categorie Gevarenaanduiding Pictogram, signaalwoord Gevarenaanduiding Aanvullende gevarenaanduiding „047-003-00-3 zilverzinkzeoliet (zeoliet, type LTA, oppervlakte gewijzigd met zilver- en zinkionen) [Deze rubriek betreft zeoliet van het type LTA (Linde-type A) waarvan de oppervlakte is gewijzigd met zowel zilver- als zinkionen met de gehalten Ag+ 0,5 % — 6 %, Zn2 + 5 % — 16 %, en eventueel met fosfor, NH4+, mg2+ en/of Ca2+, telkens < 3 %] — 130328-20-0 Repr. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H361d H315 H318 H400 H410 GHS08 GHS05 GHS09 Dgr H361d H315 H318 H410 M = 100 M = 100” „048-012-00-5 cadmiumcarbonaat 208-168-9 513-78-0 Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H340 H332 H312 H302 H372 (nier, bot) H400 H410 GHS08 GHS07 GHS09 Dgr H350 H340 H332 H312 H302 H372 (nier, bot) H410 A1” „048-013-00-0 cadmiumhydroxide; cadmiumdihydroxide 244-168-5 21041-95-2 Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H340 H332 H312 H302 H372 (nier, bot) H400 H410 GHS08 GHS07 GHS09 Dgr H350 H340 H332 H312 H302 H372 (nier, bot) H410 A1” „048-014-00-6 cadmiumnitraat; cadmiumdinitraat 233-710-6 10325-94-7 Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H340 H332 H312 H302 H372 (nier, bot) H400 H410 GHS08 GHS07 GHS09 Dgr H350 H340 H332 H312 H302 H372 (nier, bot) H410 Carc. 1B; H350: C ≥ 0,01 % A1” „050-030-00-3 dibutyltindilauraat; dibutyl[bis(dodecanoyloxy)]stannaan 201-039-8 77-58-7 Muta. 2 Repr. 1B STOT RE 1 H341 H360FD H372 (immuunsysteem) GHS08 Dgr H341 H360FD H372 (immuunsysteem)” „603-235-00-2 linalool; 3,7-dimethyl-1,6-octadieen-3-ol; dl-linalool; [1] coriandrol; (S)-3,7-dimethyl-1,6-octadieen-3-ol; d-linalool; [2] licareol; (R)-3,7-dimethyl-1,6-octadieen-3-ol; l-linalool [3] 201-134-4 [1] 204-810-7 [2] 204-811-2 [3] 78-70-6 [1] 126-90-9 [2] 126-91-0 [3] Skin Sens. 1B H317 GHS07 Wng H317” „604-093-00-4 chlorofeen; 2-benzyl-4-chloorfenol 204-385-8 120-32-1 Carc. 2 Repr. 2 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Eye Dam. 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H361f H332 H315 H317 H318 H373 (nier) H400 H410 GHS08 GHS05 GHS07 GHS09 Dgr H351 H361f H332 H315 H317 H318 H373 (nier) H410 M = 1 M = 100” „606-150-00-9 clethodim (ISO); (5RS)-2-{(1EZ)-1-[(2E)-3-chloorallyloxyimino]propyl}-5-[(2RS)-2-(ethylthio)propyl]-3-hydroxycyclohex-2-en-1-on — 99129-21-2 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 3 H302 H317 H412 GHS07 Wng H302 H317 H412 EUH066” „606-151-00-4 antrachinon 201-549-0 84-65-1 Carc. 1B H350 GHS08 Dgr H350” „607-720-00-X nonadecafluordecaanzuur; [1] ammoniumnonadecafluordecanoaat; [2] natriumnonadecafluordecanoaat [3] 206-400-3 [1] 221-470-5 [2] [3] 335-76-2 [1] 3108-42-7 [2] 3830-45-3 [3] Carc. 2 Repr. 1B Lact. H351 H360Df H362 GHS08 Dgr H351 H360Df H362” „607-721-00-5 N,N′-methyleendimorfoline; N,N′-methyleenbismorfoline; [uit N,N′-methyleenbismorfoline vrijkomende formaldehyde]; [MBM] 227-062-3 5625-90-1 Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Skin Sens. 1 Eye Dam. 1 H350 H341 H332 H312 H302 H373 (spijsverteringskanaal, luchtwegen) H314 H317 H318 GHS08 GHS07 GHS05 Dgr H350 H341 H332 H312 H302 H373 (spijsverteringskanaal, luchtwegen) H314 H317 EUH071 8 9” „607-722-00-0 2,3,5,6-tetrafluor-4-(methoxymethyl)benzyl-(Z)-(1R,3R)-3-(2-cyaanprop-1-enyl)-2,2-dimethylcyclopropaan-carboxylaat; epsilon-momfluorothrine — 1065124-65-3 Acute Tox. 4 STOT SE 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H371 (zenuwstelsel) H400 H410 GHS07 GHS08 GHS09 Wng H302 H371 (zenuwstelsel) H410 M = 100 M = 100” „607-723-00-6 tefluthrin (ISO); 2,3,5,6-tetrafluor-4-methylbenzyl-(1RS,3RS)-3-[(Z)-2-chloor-3,3,3-trifluorprop-1-enyl]-2,2-dimethylcyclopropaan-carboxylaat — 79538-32-2 Acute Tox. 1 Acute Tox. 2 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H300 H400 H410 GHS06 GHS09 Dgr H330 H310 H300 H410 M = 10 000 M = 10 000 ” „612-290-00-1 reactieproducten van paraformaldehyde en 2-hydroxypropylamine (verhouding 3:2); [uit 3,3′-methyleenbis[5-methyloxazolidine] vrijkomende formaldehyde; uit oxazolidine vrijkomende formaldehyde]; [MBO] — — Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 3 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Eye Dam. 1 Skin Sens. 1A Aquatic Chronic 2 H350 H341 H332 H311 H302 H373 (spijsverteringskanaal, luchtwegen) H314 H318 H317 H411 GHS08 GHS06 GHS05 GHS09 Dgr H350 H341 H332 H311 H302 H373 (spijsverteringskanaal, luchtwegen) H314 H317 H411 EUH071 8 9” „612-291-00-7 reactieproducten van paraformaldehyde met 2-hydroxypropylamine (verhouding 1:1); [uit α,α,α-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol vrijkomende formaldehyde]; [HPT] — — Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Corr. 1C Eye Dam. 1 Skin Sens. 1A Aquatic Chronic 2 H350 H341 H332 H302 H373 (spijsverteringskanaal, luchtwegen) H314 H318 H317 H411 GHS08 GHS07 GHS05 GHS09 Dgr H350 H341 H332 H302 H373 (spijsverteringskanaal, luchtwegen) H314 H317 H411 EUH071 8 9” „612-292-00-2 methylhydrazine 200-471-4 60-34-4 Carc. 1B H350 GHS08 Dgr H350” „613-321-00-1 (RS)-4-[1-(2,3-dimethylfenyl)ethyl]-1H-imidazool; medetomidine — 86347-14-0 Acute Tox. 2 Acute Tox. 2 STOT SE 3 STOT SE 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H300 H336 H370 (oog) H372 H400 H410 GHS06 GHS08 GHS09 Dgr H330 H300 H336 H370 (oog) H372 H410 M = 1 M = 100” „613-322-00-7 triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-chloorfenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazool-1-yl)butaan-2-ol; α-tert-butyl-β-(4-chloorfenoxy)-1H-1,2,4-triazool-1-ethanol 259-537-6 55219-65-3 Repr. 1B Lact. Acute Tox. 4 Aquatic Chronic 2 H360 H362 H302 H411 GHS08 GHS07 GHS09 Dgr H360 H362 H302 H411” „613-323-00-2 terbutylazine (ISO); N-tert-butyl-6-chloor-N′-ethyl-1,3,5-triazine-2,4-diamine 227-637-9 5915-41-3 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H400 H410 GHS07 GHS08 GHS09 Wng H302 H373 H410 M = 10 M = 10” „613-324-00-8 chinoline-8-ol; 8-hydroxychinoline 205-711-1 148-24-3 Repr. 1B Acute Tox. 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H301 H318 H317 H400 H410 GHS08 GHS06 GHS05 GHS09 Dgr H360D H301 H318 H317 H410 M = 1 M = 1” „613-325-00-3 thiacloprid (ISO); (Z)-3-(6-chloor-3-pyridylmethyl)-1,3-thiazolidine-2-ylideencyaanamide; {(2Z)-3-[(6-chloorpyridine-3-yl)methyl]-1,3-thiazolidine-2-ylideen}cyaanamide — 111988-49-9 Carc. 2 Repr. 1B Acute Tox. 4 Acute Tox. 3 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H351 H360FD H332 H301 H336 H400 H410 GHS08 GHS06 GHS09 Dgr H351 H360FD H332 H301 H336 H410 M = 100 M = 100” „616-221-00-6 hexaflumuron (ISO); 1-(3,5-dichloor-4-(1,1,2,2-tetrafluorethoxy)fenyl)-3-(2,6-difluorbenzoyl)ureum 401-400-1 86479-06-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 1 000 M = 10 000 ” „616-222-00-1 penthiopyrad (ISO); (RS)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluormethyl)pyrazool-4-carboxamide — 183675-82-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 1 M = 1” „616-223-00-7 carbetamide (ISO); (R)-1-(ethylcarbamoyl)ethyl-carbanilaat; (2R)-1-(ethylamino)-1-oxopropaan-2-yl-fenylcarbamaat 240-286-6 16118-49-3 Carc. 2 Repr. 1B Acute Tox. 4 Aquatic Chronic 2 H351 H360D H302 H411 GHS08 GHS07 GHS09 Dgr H351 H360D H302 H411” ( *1 ) Omgerekende puntschattingen van de acute toxiciteit overeenkomstig tabel 3.1.2 van bijlage I.",
  "source": "EUR LEX"
}